Infection relapse in spondyloarthritis treated with biological drugs: a single-centre study

Scand J Rheumatol. 2012;41(6):490-1. doi: 10.3109/03009742.2012.698393. Epub 2012 Sep 18.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adalimumab
  • Adult
  • Aged
  • Antibodies, Monoclonal / adverse effects
  • Antibodies, Monoclonal / therapeutic use
  • Antibodies, Monoclonal, Humanized / adverse effects
  • Antibodies, Monoclonal, Humanized / therapeutic use
  • Antirheumatic Agents / adverse effects
  • Antirheumatic Agents / therapeutic use*
  • Arthritis, Psoriatic / complications
  • Arthritis, Psoriatic / drug therapy*
  • Etanercept
  • Female
  • Humans
  • Immunoglobulin G / adverse effects
  • Immunoglobulin G / therapeutic use
  • Infections / etiology*
  • Infliximab
  • Male
  • Middle Aged
  • Receptors, Tumor Necrosis Factor / therapeutic use
  • Recurrence
  • Severity of Illness Index
  • Spondylarthritis / complications
  • Spondylarthritis / drug therapy*
  • Spondylitis, Ankylosing / complications
  • Spondylitis, Ankylosing / drug therapy*

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Antirheumatic Agents
  • Immunoglobulin G
  • Receptors, Tumor Necrosis Factor
  • Infliximab
  • Adalimumab
  • Etanercept